SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001571049-17-003364
Filing Date
2017-04-11
Accepted
2017-04-11 12:04:52
Documents
7
Effectiveness Date
2017-04-11

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT t1700949-defm14a.htm DEFM14A 2605979
2 GRAPHIC lg_caladrius.jpg GRAPHIC 208381
3 GRAPHIC sg_david-mazzo.jpg GRAPHIC 24132
4 GRAPHIC sg_mts-securities.jpg GRAPHIC 26375
5 GRAPHIC sg_todd-girolamo.jpg GRAPHIC 21694
6 GRAPHIC t1700949_pc01.jpg GRAPHIC 486927
7 GRAPHIC t1700949_pc02.jpg GRAPHIC 286109
  Complete submission text file 0001571049-17-003364.txt   4039274
Mailing Address 106 ALLEN ROAD FOURTH FLOOR BASKING RIDGE NJ 07920
Business Address 106 ALLEN ROAD FOURTH FLOOR BASKING RIDGE NJ 07920 908-842-0100
Caladrius Biosciences, Inc. (Filer) CIK: 0000320017 (see all company filings)

IRS No.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-33650 | Film No.: 17755403
SIC: 8090 Services-Misc Health & Allied Services, NEC
Assistant Director 9